ArticleFrontiers in immunology2022

A Novel Bacterial Protease Inhibitor Adjuvant in RBD-Based COVID-19 Vaccine Formulations Containing Alum Increases Neutralizing Antibodies, Specific Germinal Center B Cells and Confers Protection Against SARS-CoV-2 Infection in Mice.

Lorena M Coria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.